Education
About Us
Working with TipRanks
Follow Us
Aarey Drugs & Pharmaceuticals Ltd. (IN:AAREYDRUGS)
:AAREYDRUGS
RESEARCH TOOLSreports
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 4.74B | ₹ 3.95B | ₹ 4.14B | ₹ 4.92B | ₹ 3.48B |
| Gross Profit | ₹ 91.32M | ₹ 132.04M | ₹ 104.12M | ₹ 195.45M | ₹ 100.98M |
| Operating Income | ₹ 3.06M | ₹ 28.25M | ₹ 66.92M | ₹ 100.27M | ₹ 82.31M |
| EBITDA | ₹ 120.64M | ₹ 114.16M | ₹ 82.66M | ₹ 120.15M | ₹ 91.51M |
| Net Income | ₹ 40.24M | ₹ 46.84M | ₹ 37.71M | ₹ 65.55M | ₹ 65.14M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 14.73M | ₹ 28.90M | ₹ 11.24M | ₹ 1.92M | ₹ 6.50M |
| Total Assets | ₹ 2.38B | ₹ 3.03B | ₹ 2.91B | ₹ 2.45B | ₹ 2.33B |
| Total Debt | ₹ 348.56M | ₹ 313.52M | ₹ 377.18M | ₹ 141.62M | ₹ 180.17M |
| Net Debt | ₹ 333.83M | ₹ 297.58M | ₹ 370.12M | ₹ 139.71M | ₹ 173.80M |
| Total Liabilities | ₹ 997.86M | ₹ 1.71B | ₹ 1.74B | ₹ 1.32B | ₹ 1.34B |
| Stockholders' Equity | ₹ 1.38B | ₹ 1.33B | ₹ 1.17B | ₹ 1.14B | ₹ 988.60M |
| Cash Flow | |||||
| Free Cash Flow | ₹ -43.10M | ₹ -37.16M | ₹ -23.25M | ₹ -66.94M | ₹ 25.98M |
| Operating Cash Flow | ₹ 8.95M | ₹ -29.94M | ₹ -12.81M | ₹ -44.93M | ₹ 54.77M |
| Investing Cash Flow | ₹ -59.39M | ₹ -17.02M | ₹ 4.41M | ₹ -21.97M | ₹ -28.79M |
| Financing Cash Flow | ₹ 49.24M | ₹ 55.85M | ₹ 13.54M | ₹ 62.32M | ₹ -24.51M |